Manhattan Scients (MHTX) 0.0496 $MHTX Ex-GE Healthcare

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Manhattan Scients (MHTX) 0.0496 $MHTX

Ex-GE Healthcare CTO Michael J. Harsh Joins Manhattan Scientifics Advisory Board
BusinessWire - Tue Mar 29, 8:00AM CDT
Manhattan Scientifics, Inc. (MHTX: OTCQB) announced today that Michael J. Harsh, former VP & Chief Technology Officer for GE Healthcare and a recognized global expert on medical imaging technology, has joined the Company's Science and Technology Advisory Board.

Senior Scientific Teams Up With University of Michigan On In Vivo Breast Cancer Diagnostic
BusinessWire - Wed Jan 13, 8:00AM CST
Manhattan Scientifics, Inc. (OTCQB: MHTX) announced today that its Senior Scientific unit, developing a platform for the early detection of cancer and other human diseases, has established a Research Collaboration with The University of Michigan Medical School. The collaboration's goal is to demonstrate the applicability of the company's magnetic relaxometry technology for diagnosing and staging breast cancers.

Senior Scientific Extends Collaboration with MD Anderson Cancer Center
BusinessWire - Mon Dec 14, 8:00AM CST
Manhattan Scientifics, Inc. (OTCQB: MHTX) announced today that its Senior Scientific, LLC unit, developing a platform for the early detection of cancer and other human diseases, has renewed its Collaboration Agreement with The University of Texas MD Anderson Cancer Center, establishing a multi-year program with extended scope. The agreement calls for MD Anderson to participate in a rigorous development program to translate the pre-clinical research to first use in humans.

Manhattan Scientifics Announces Chinese Patent Issued for the Early Cancer Detection Technology Platform
BusinessWire - Mon Oct 26, 8:36AM CDT
Senior Scientific, LLC, a unit of Manhattan Scientifics (MHTX: OTCQB) and a developer of nanobiotechnology for the early detection and localization of cancer and other human diseases, today announced that the Company has recently been granted a patent by the Chinese Patent Office, Patent No. CN102695473 A, covering the "Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof." This patent is an additional patent granted for its MRX(TM) cancer detection technology that has been granted and issued in by the U.S. Patent office under U.S. Patent No. US 9,095,270 B2.

Manhattan Scientifics Announces Issuance of Additional Patent Covering Detection and Imaging of Cancer Cells
BusinessWire - Mon Aug 10, 8:00AM CDT
Manhattan Scientifics, Inc. (OTCQB:MHTX) announced today that its Senior Scientific, LLC unit, a nanobiotechnology company for the early detection and localization of cancer and other human diseases, has been granted an additional United States Patent for its MRX(TM) cancer detection technology. U.S. Patent No. US 9,095,270 B2 entitled "Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof." The patent provides a method as well as an apparatus for detecting and measuring cancer cells, using magnetic nanoparticles.

Manhattan Scientifics Engages Services of Torreya Partners
BusinessWire - Thu Jul 16, 8:00AM CDT
Manhattan Scientifics, Inc. (MSI) (OTCQB:MHTX) today announced the engagement of Torreya Partners and its professional services sister company, Torreya Insights.

Manhattan Scientifics Issues Letter from the New President of its Senior Scientific Subsidiary
BusinessWire - Fri May 08, 8:53AM CDT
Manhattan Scientifics, Inc. (MSI) (OTCQB: MHTX) released a Letter from the New President of Senior Scientific LLC that was filed as an 8k with the U.S. Securities and Exchange Commission.

Manhattan Scientifics Issues Letter to Shareholders
BusinessWire - Mon Apr 20, 10:14AM CDT
Manhattan Scientifics, Inc. (MSI) (OTCQB:MHTX) released a Letter to Shareholders today that was filed as an 8k with the U.S. Securities and Exchange Commission.

Manhattan Scientifics Announces Return of Marvin Maslow as Chairman of the Board
BusinessWire - Wed Mar 25, 8:00AM CDT
Manhattan Scientifics, Inc. (MSI) (OTCQB: MHTX) announced today that Marvin Maslow, founder of MSI, has re-joined the Company's Board of Directors as Chairman.

Manhattan Scientifics to Immediately Receive $8 Million as it Reacquires its Nano-Structured Metals Technology and Related Intellectual Property and Equipment
BusinessWire - Wed Feb 18, 8:15AM CST
Manhattan Scientifics, Inc. (OTCQB: MHTX) has reacquired all rights in its nano-structured metals technology from its former Licensee whose strategic corporate priorities had changed. The agreement includes a one-time payment to Manhattan of $8 million, the assignment to Manhattan of all related IP and the transfer of ownership of various ECAP machinery and equipment used in the manufacturing process of nano-structured metals. The additional non-cash value of this transaction exceeds $10 million.

Manhattan Scientifics Recruits Robert R. Proulx as Its New President and Chief Operating Officer for Its Senior Scientific Subsidiary
BusinessWire - Wed Jan 14, 8:00AM CST
Manhattan Scientifics, Inc. (OTCQB:MHTX) has recruited Robert R. Proulx (pronounced "Pru" to the position of President and Chief Operating Officer of its Senior Scientific LLC subsidiary, effective January 12. As previously announced, Gerald Grafe, former president of Senior Scientific, is remaining with Senior Scientific to focus on strategic relationships and intellectual property issues. Edward R. Flynn, PhD, founder of Senior Scientific, is remaining as Chief Scientist.

Manhattan Scientifics Announces Expansion of Executive Team at Its Senior Scientific Subsidiary
BusinessWire - Tue Dec 30, 10:00AM CST
Manhattan Scientifics, Inc. (OTCQB:MHTX) is recruiting a seasoned executive to oversee Senior Scientific's next stage of product development for its MRX diagnostic technology for the early detection of cancer. The new President and COO candidate under consideration, has a strong background in the life sciences and experience in diagnostic medical product development. The new President/COO will be responsible for expanding the collaborations in place with the MD Anderson Cancer Center in Houston and The University of New Mexico Health Sciences Center, Albuquerque, to help further develop this technology.

Manhattan Scientifics raises USD2.0m equity
M2 - Mon Nov 24, 8:15AM CST
Manhattan Scientifics, Inc. (OTC: MHTX) said it has completed a USD2.0 million equity raise.

Manhattan Scientifics Completes $2.0 Million Equity Raise
BusinessWire - Fri Nov 21, 8:00AM CST
Manhattan Scientifics, Inc. (OTCQB:MHTX) (the "Company" has completed a $2.0 million equity raise. Details of the raise are available in the Company's November 18th 8K filing with the SEC. The proceeds will primarily be used to fund the advancement, demonstration and validation of its MRX cancer diagnostic technology under development by its subsidiary, Senior Scientific, LLC.

Manhattan Scientifics Engages Dian Griesel Int'l.
BusinessWire - Thu Oct 30, 6:45AM CDT
Manhattan Scientifics, Inc. (OTCQB: MHTX) has engaged Dian Griesel Int'l. (DGI) to manage media relations. DGI will work toward the objective of increasing awareness of the company and its subsidiary Senior Scientific LLC, which has developed and patented technologies that use bio safe nanoparticles and sensitive magnetic sensors to detect and measure cancer cells more rapidly and less expensively than current methods.

SeeThruEquity Issues Company Note on Manhattan Scientifics, Highlighting MRX Technology Featured in MD Anderson Presentation
ACCESSWIRE - Mon Oct 13, 8:00AM CDT
New York, NY / ACCESSWIRE / October 13, 2014 / SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a company note on Manhattan Scientifics, Inc. (OTCQB: MHTX).

Manhattan Scientifics' Unparalleled Cancer Measurement Technology Featured in MD Anderson Presentation
BusinessWire - Wed Oct 08, 7:49AM CDT
Senior Scientific LLC, a subsidiary of Manhattan Scientifics, Inc. (OTCQB: MHTX), is currently collaborating with The University of Texas MD Anderson Cancer Center (MDACC) to advance, demonstrate and validate a cancer detection and measurement technology originally developed by Edward R. Flynn, PhD. John D. Hazle, PhD of the MD Anderson Cancer Center recently presented initial results from the collaboration in a poster at the World Molecular Imaging Conference in Seoul, South Korea. The link to the results can be found here - http://www.mhtx.com/wmic/2014-poster.pdf.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 205

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 286

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 327

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 207

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 221

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 330

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 299

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 287

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 264

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading

Top 5 Most Recently Viewed Articles

Elis Capital Structure Overview and Voting Rights Update

Updated Category News Views 292

Elis Capital Structure Overview Elis, a prominent player in the services sector, is committed to providing transparency regarding its capital structure. As of the recent assessment, the company detailed the number of shares that constitute its capital along with the total number of voting rights. Share Capital and Voting Rights According to French legal requirements,...

Continue Reading
A. Walker & Company Secures $50 Million for Housing Projects

Updated Category News Views 244

A. Walker & Company Secures Major Capital Commitments A. Walker & Co. recently secured a significant capital commitment totaling up to $75 million, including an initial $50 million specifically set aside for affordable housing development. This funding is a critical step towards increasing the availability of multifamily housing that can effectively serve the needs of...

Continue Reading
ClorDiSys Enhances Sterilization Capabilities with Expansion

Updated Category News Views 228

ClorDiSys Expands Sterilization Operations ClorDiSys Solutions, LLC has announced a significant expansion in its sterilization facilities, designed to address the growing demand for its chlorine dioxide-based sterilization services. This expansion includes the addition of new chambers, which will effectively double the company’s processing capacity. With the new...

Continue Reading
Star Equity's KBS Builders Secures Major Contracts Worth $5.2M

Updated Category News Views 173

KBS Builders Secures Significant Commercial Contracts Star Equity Holdings, Inc. is excited to announce that its subsidiary, KBS Builders, has successfully signed two major contracts worth a total of $5.2 million. These contracts focus on the manufacturing of housing units, promising to contribute positively not only to KBS's growth but also to addressing the ongoing...

Continue Reading
Navigating the Startup Jungle: Break Free from Traps

Updated Category News Views 158

Understanding the Existing Market Trap A fresh approach from the creators of Play Bigger reveals the hidden costs startups face. The new book titled The Existing Market Trap: A Primer presents a timely exploration into why many startups struggle to gain traction. Co-authors Al Ramadan, Christopher Lochhead, alongside new contributors Jason Wellcome and Mary Gr

Continue Reading